Optimal diagnosis and management of common nail disorders

References

• van de Kerkhof PC, Pasch MC, Scher RK, et al. Brittle nail syndrome: a pathogenesis-based approach with a proposed grading system. J Am Acad Dermatol. 2005;53(4):644–651.
   PubMed Web of Science ®Google Scholar
• Iorizzo M, Pazzaglia M, Piraccini BM, et al. Brittle nails. J Cosmet Dermatol. 2004;3(3):138–144.
   PubMedGoogle Scholar
• Chessa MA, Iorizzo M, Richert B, et al. Pathogenesis, clinical signs and treatment recommendations in brittle nails: a review [published correction appears in Dermatol Ther (Heidelb). 2020 Jan 22]. Dermatol Ther (Heidelb). 2020;10(1):15–27.
   PubMed Web of Science ®Google Scholar
• Shemer A, Daniel CR III. Common nail disorders. Clin Dermatol. 2013;31(5):578–586.
   PubMed Web of Science ®Google Scholar
• Baran R, Schoon D. Nail fragility syndrome and its treatment. J Cosmet Dermatol. 2004;3(3):131–137.
   PubMedGoogle Scholar
• Dahdah MJ, Scher RK. Nail diseases related to nail cosmetics. Dermatol Clin. 2006;24(2):233–239.
   PubMed Web of Science ®Google Scholar
• Haneke E. Onychocosmeceuticals. J Cosmet Dermatol. 2006;5(1):95–100.
   PubMedGoogle Scholar
• Iorizzo M. Tips to treat the 5 most common nail disorders: brittle nails, onycholysis, paronychia, psoriasis, onychomycosis. Dermatol Clin. 2015;33(2):175–183.
   PubMed Web of Science ®Google Scholar
• John JJ, Cooley V, Lipner SR. Assessment of biotin supplementation among patients in an outpatient dermatology clinic. J Am Acad Dermatol. 2019;81(2):620–621.
   PubMed Web of Science ®Google Scholar
• Lipner SR. Update on biotin therapy in dermatology: time for a change. J Drugs Dermatol. 2020;19(12):1264–1265.
   PubMed Web of Science ®Google Scholar
• Maddy AJ, Tosti A. What’s new in nail disorders. Dermatol Clin. 2019;37(2):143–147.
   PubMed Web of Science ®Google Scholar
• Finlay AY, Frost P, Keith AD, et al. An assessment of factors influencing flexibility of human fingernails. Br J Dermatol. 1980;103(4):357–365.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Versteeg SG, Shear NH. Onychomycosis in the 21st century: an update on diagnosis, epidemiology, and treatment. J Cutan Med Surg. 2017;21(6):525–539.
   PubMed Web of Science ®Google Scholar
• Lipner SR, Scher RK. Onychomycosis: clinical overview and diagnosis. J Am Acad Dermatol. 2019;80(4):835–851.
   PubMed Web of Science ®Google Scholar
• Cozzani E, Agnoletti AF, Speziari S, et al. Epidemiological study of onychomycosis in older adults with onychodystrophy. Geriatr Gerontol Int. 2016;16(4):486–491.
   PubMed Web of Science ®Google Scholar
• Stewart CR, Algu L, Kamran R, et al. Effect of onychomycosis and treatment on patient-reported quality-of-life outcomes: a systematic review. J Am Acad Dermatol. 2021;85(5):1227–1239.
   PubMed Web of Science ®Google Scholar
• Beuscher TL, Kelechi TJ. Onychomycosis: diagnosis, treatment, and prevention. J Wound Ostomy Continence Nurs. 2019;46(4):333–335.
   PubMed Web of Science ®Google Scholar
• Ramesh V, Reddy BS, Singh R. Onychomycosis. Int J Dermatol. 1983;22(3):148–152.
   PubMed Web of Science ®Google Scholar
• Leung AKC, Lam JM, Leong KF, et al. Onychomycosis: an updated review. Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):32–45.
   PubMed Web of Science ®Google Scholar
• Lipner SR, Scher RK. Evaluation of nail lines: color and shape hold clues. Cleve Clin J Med. 2016;83(5):385–391.
   PubMed Web of Science ®Google Scholar
• Piraccini BM, Alessandrini A. Onychomycosis: a review. J Fungi (Basel). 2015;1(1):30–43.
   PubMedGoogle Scholar
• Pichardo-Geisinger R, Mora DC, Newman JC, et al. Comorbidity of tinea pedis and onychomycosis and evaluation of risk factors in Latino immigrant poultry processing and other manual laborers. South Med J. 2014;107(6):374–379.
   PubMed Web of Science ®Google Scholar
• Mahoney JM, Bennet J, Olsen B. The diagnosis of onychomycosis. Dermatol Clin. 2003;21(3):463–467.
   PubMed Web of Science ®Google Scholar
• Hay RJ, Baran R. Onychomycosis: a proposed revision of the clinical classification. J Am Acad Dermatol. 2011;65(6):1219–1227.
   PubMed Web of Science ®Google Scholar
• Piraccini BM, Tosti A. White superficial onychomycosis: epidemiological, clinical, and pathological study of 79 patients. Arch Dermatol. 2004;140(6):696–701.
   PubMed Web of Science ®Google Scholar
• Hay RJ, Baran R, Moore MK, et al. Candida onychomycosis-an evaluation of the role of Candida species in nail disease. Br J Dermatol. 1988;118(1):47–58.
   PubMed Web of Science ®Google Scholar
• Lipner SR, Scher RK. Confirmatory testing for onychomycosis. JAMA Dermatol. 2016;152(7):847.
   PubMed Web of Science ®Google Scholar
• Lipner SR, Scher RK. Onychomycosis - a small step for quality of care. Curr Med Res Opin. 2016;32(5):865–867.
   PubMed Web of Science ®Google Scholar
• Allevato MA. Diseases mimicking onychomycosis. Clin Dermatol. 2010;28(2):164–177.
   PubMed Web of Science ®Google Scholar
• Queller JN, Bhatia N. The dermatologist's approach to onychomycosis. J Fungi (Basel). 2015;1(2):173–184.
   PubMedGoogle Scholar
• Yorulmaz A, Yalcin B. Dermoscopy as a first step in the diagnosis of onychomycosis. Postepy Dermatol Alergol. 2018;35(3):251–258.
   PubMed Web of Science ®Google Scholar
• Piraccini BM, Bruni F, Starace M. Dermoscopy of non-skin cancer nail disorders. Dermatol Ther. 2012;25(6):594–602.
   PubMed Web of Science ®Google Scholar
• Jesús-Silva MA, Fernández-Martínez R, Roldán-Marín R, et al. Dermoscopic patterns in patients with a clinical diagnosis of onychomycosis-results of a prospective study including data of potassium hydroxide (KOH) and culture examination. Dermatol Pract Concept. 2015;5(2):39–44.
   PubMedGoogle Scholar
• Meireles TE, Rocha MF, Brilhante RS, et al. Successive mycological nail tests for onychomycosis: a strategy to improve diagnosis efficiency. Braz J Infect Dis. 2008;12(4):333–337.
   PubMed Web of Science ®Google Scholar
• Ghannoum M, Mukherjee P, Isham N, et al. Examining the importance of laboratory and diagnostic testing when treating and diagnosing onychomycosis. Int J Dermatol. 2018;57(2):131–138.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Stec N, Summerbell RC, et al. Onychomycosis: a review. J Eur Acad Dermatol Venereol. 2020;34(9):1972–1990.
   PubMed Web of Science ®Google Scholar
• Westerberg DP, Voyack MJ. Onychomycosis: current trends in diagnosis and treatment. Am Fam Physician. 2013;88(11):762–770.
   PubMed Web of Science ®Google Scholar
• Cathcart S, Cantrell W, Elewski B. Onychomycosis and diabetes. J Eur Acad Dermatol Venereol. 2009;23(10):1119–1122.
   PubMed Web of Science ®Google Scholar
• Loo DS. Onychomycosis in the elderly: drug treatment options. Drugs Aging. 2007;24(4):293–302.
   PubMed Web of Science ®Google Scholar
• Aggarwal R, Targhotra M, Kumar B, et al. Treatment and management strategies of onychomycosis. J Mycol Med. 2020;30(2):100949.
   PubMed Web of Science ®Google Scholar
• Gupta AK. Ciclopirox: an overview. Int J Dermatol. 2001;40(5):305–310.
   PubMed Web of Science ®Google Scholar
• Lipner SR, Scher RK. Onychomycosis: Treatment and prevention of recurrence. J Am Acad Dermatol. 2019;80(4):853–867.
   PubMed Web of Science ®Google Scholar
• Eichenfield LF, Friedlander SF. Pediatric onychomycosis: the emerging role of topical therapy. J Drugs Dermatol. 2017;16(2):105–109.
   PubMed Web of Science ®Google Scholar
• Solís-Arias MP, García-Romero MT. Onychomycosis in children. A review. Int J Dermatol. 2017;56(2):123–130.
   PubMed Web of Science ®Google Scholar
• Jennings MB, Pollak R, Harkless LB, et al. Treatment of toenail onychomycosis with oral terbinafine plus aggressive debridement: IRON-CLAD, a large, randomized, open-label, multicenter trial. J Am Podiatr Med Assoc. 2006;96(6):465–473.
   PubMed Web of Science ®Google Scholar
• Malay DS, Yi S, Borowsky P, et al. Efficacy of debridement alone versus debridement combined with topical antifungal nail lacquer for the treatment of pedal onychomycosis: a randomized, controlled trial. J Foot Ankle Surg. 2009;48(3):294–308.
   PubMed Web of Science ®Google Scholar
• Dulski A, Edwards CW. Paronychia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; August 10, 2020.
   Google Scholar
• Gupta MK, Lipner SR. Review of chemotherapy-associated paronychia [published online ahead of print, 2021 July 9]. Int J Dermatol. 2021.
   Web of Science ®Google Scholar
• Leggit JC. Acute and chronic paronychia. Am Fam Physician. 2017;96(1):44–51.
   PubMed Web of Science ®Google Scholar
• Lomax A, Thornton J, Singh D. Toenail paronychia. Foot Ankle Surg. 2016;22(4):219–223.
   PubMed Web of Science ®Google Scholar
• Shafritz AB, Coppage JM. Acute and chronic paronychia of the hand. J Am Acad Orthop Surg. 2014;22(3):165–174.
   PubMed Web of Science ®Google Scholar
• Tully AS, Trayes KP, Studdiford JS. Evaluation of nail abnormalities. Am Fam Physician. 2012;85(8):779–787.
   PubMed Web of Science ®Google Scholar
• Rerucha CM, Ewing JT, Oppenlander KE, et al. Acute hand infections. Am Fam Physician. 2019;99(4):228–236.
   PubMed Web of Science ®Google Scholar
• Rockwell PG. Acute and chronic paronychia. Am Fam Physician. 2001;63(6):1113–1116.
   PubMed Web of Science ®Google Scholar
• Rigopoulos D, Larios G, Gregoriou S, et al. Acute and chronic paronychia. Am Fam Physician. 2008;77(3):339–346.
   PubMed Web of Science ®Google Scholar
• Tosti A, Piraccini BM, D'Antuono A, et al. Paronychia associated with antiretroviral therapy. Br J Dermatol. 1999;140(6):1165–1168.
   PubMed Web of Science ®Google Scholar
• Relhan V, Goel K, Bansal S, et al. Management of chronic paronychia. Indian J Dermatol. 2014;59(1):15–20.
   PubMed Web of Science ®Google Scholar
• Jebson PJ. Infections of the fingertip. Paronychias and felons. Hand Clin. 1998;14(4):547–555.
   PubMed Web of Science ®Google Scholar
• Hochman LG. Paronychia: more than just an abscess. Int J Dermatol. 1995;34(6):385–386.
   PubMed Web of Science ®Google Scholar
• Gorva AD, Mohil R, Srinivasan MS. Aggressive digital papillary adenocarcinoma presenting as a paronychia of the finger. J Hand Surg Br. 2005;30(5):534.
   PubMedGoogle Scholar
• Sollena P, Mannino M, Tassone F, et al. Efficacy of topical beta-blockers in the management of EGFR-inhibitor induced paronychia and pyogenic granuloma-like lesions: case series and review of the literature. Drugs Context. 2019;8:212613.
   PubMedGoogle Scholar
• Lacouture ME, Anadkat MJ, Bensadoun RJ, et al. Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities. Support Care Cancer. 2011;19(8):1079–1095.
   PubMed Web of Science ®Google Scholar
• Turkmen A, Warner RM, Page RE. Digital pressure test for paronychia. Br J Plast Surg. 2004;57(1):93–94.
   PubMedGoogle Scholar
• Macneal P, Milroy C. Paronychia drainage. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021.
   Google Scholar
• Anakwenze OA, Milby AH, Gans I, et al. Foot and ankle infections: diagnosis and management. J Am Acad Orthop Surg. 2012;20(11):684–693.
   PubMed Web of Science ®Google Scholar
• Wollina U. Acute paronychia: comparative treatment with topical antibiotic alone or in combination with corticosteroid. J Eur Acad Dermatol Venereol. 2001;15(1):82–84.
   PubMed Web of Science ®Google Scholar
• Pierrart J, Delgrande D, Mamane W, et al. Acute felon and paronychia: antibiotics not necessary after surgical treatment. Prospective study of 46 patients. Hand Surg Rehabil. 2016;35(1):40–43.
   PubMed Web of Science ®Google Scholar
• Barger J, Garg R, Wang F, et al. Fingertip infections. Hand Clin. 2020;36(3):313–321.
   PubMed Web of Science ®Google Scholar
• Tosti A, Piraccini BM, Ghetti E, et al. Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double-blind and double dummy study. J Am Acad Dermatol. 2002;47(1):73–76.
   PubMed Web of Science ®Google Scholar
• Kozuki T. Skin problems and EGFR-tyrosine kinase inhibitor. Jpn J Clin Oncol. 2016;46(4):291–298.
   PubMed Web of Science ®Google Scholar
• Beech J, Germetaki T, Judge M, et al. Management and grading of EGFR inhibitor-induced cutaneous toxicity. Future Oncol. 2018;14(24):2531–2541.
   PubMed Web of Science ®Google Scholar
• Lacouture ME, Mitchell EP, Piperdi B, et al. Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-Emptive skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer. J Clin Oncol. 2010;28(8):1351–1357.
   PubMed Web of Science ®Google Scholar
• Masago K, Irie K, Fujita S, et al. Relationship between paronychia and drug concentrations of epidermal growth factor receptor tyrosine kinase inhibitors. Oncology. 2018;95(4):251–256.
   PubMed Web of Science ®Google Scholar
• Bednar MS, Lane LB. Eponychial marsupialization and nail removal for surgical treatment of chronic paronychia. J Hand Surg Am. 1991;16(2):314–317.
   PubMed Web of Science ®Google Scholar
• Baran R, Bureau H. Surgical treatment of recalcitrant chronic paronychias of the fingers. J Dermatol Surg Oncol. 1981;7(2):106–107.
   PubMedGoogle Scholar
• Nirbhavane P, Sharma G, Verma S, et al. Nail psoriasis treatment: insights into current progress and future trends. Crit Rev Ther Drug Carrier Syst. 2020;37(2):135–159.
   PubMed Web of Science ®Google Scholar
• Pasch MC. Nail psoriasis: a review of treatment options. Drugs. 2016;76(6):675–705.
   PubMed Web of Science ®Google Scholar
• Baran R. The burden of nail psoriasis: an introduction. Dermatology. 2010;221 Suppl 1:1–5.
   PubMed Web of Science ®Google Scholar
• Reich K. Approach to managing patients with nail psoriasis. J Eur Acad Dermatol Venereol. 2009;23 Suppl 1:15–21.
   PubMed Web of Science ®Google Scholar
• Augustin M, Reich K, Blome C, et al. Nail psoriasis in Germany: epidemiology and burden of disease. Br J Dermatol. 2010;163(3):580–585.
   PubMed Web of Science ®Google Scholar
• Stewart CR, Algu L, Kamran R, et al. The impact of nail psoriasis and treatment on quality of life: a systematic review. Skin Appendage Disord. 2021;7(2):83–89.
   PubMed Web of Science ®Google Scholar
• Haneke E. Nail psoriasis: clinical features, pathogenesis, differential diagnoses, and management. Psoriasis (Auckl). 2017;7:51–63.
   PubMed Web of Science ®Google Scholar
• Dogra A, Arora AK. Nail psoriasis: the journey so far. Indian J Dermatol. 2014;59(4):319–333.
   PubMed Web of Science ®Google Scholar
• Jiaravuthisan MM, Sasseville D, Vender RB, et al. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol. 2007;57(1):1–27.
   PubMed Web of Science ®Google Scholar
• Ricardo JW, Lipner SR. Nail psoriasis in older adults: epidemiology, diagnosis, and topical therapy. Dermatol Clin. 2021;39(2):183–193.
   PubMed Web of Science ®Google Scholar
• Lipner SR, Iorizzo M. Clinical pearl: early diagnosis of nail psoriasis and psoriatic arthritis. Cutis. 2017;99(2):138.
   PubMed Web of Science ®Google Scholar
• Raposo I, Torres T. Nail psoriasis as a predictor of the development of psoriatic arthritis. Actas Dermosifiliogr. 2015;106(6):452–457.
   PubMed Web of Science ®Google Scholar
• van der Velden HM, Klaassen KM, van de Kerkhof PC, et al. Fingernail psoriasis reconsidered: a case-control study. J Am Acad Dermatol. 2013;69(2):245–252.
   PubMed Web of Science ®Google Scholar
• Rich P, Scher RK. Nail psoriasis severity index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol. 2003;49(2):206–212.
   PubMed Web of Science ®Google Scholar
• Klaassen KM, van de Kerkhof PC, Bastiaens MT, et al. Scoring nail psoriasis. J Am Acad Dermatol. 2014;70(6):1061–1066.
   PubMed Web of Science ®Google Scholar
• Bardazzi F, Starace M, Bruni F, et al. Nail psoriasis: an updated review and expert opinion on available treatments, including biologics. Acta Derm Venereol. 2019;99(6):516–523.
   PubMed Web of Science ®Google Scholar
• Rigopoulos D, Baran R, Chiheb S, et al. Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: a dermatologist and nail expert group consensus. J Am Acad Dermatol. 2019;81(1):228–240.
   PubMed Web of Science ®Google Scholar
• Uhlenhake EE, Kurkowski D, Feldman SR. Conversations on psoriasis-what patients want and what physicians can provide: a qualitative look at patient and physician expectations. J Dermatolog Treat. 2010;21(1):6–12.
   PubMed Web of Science ®Google Scholar
• de Berker DA, Lawrence CM. A simplified protocol of steroid injection for psoriatic nail dystrophy. Br J Dermatol. 1998;138(1):90–95.
   PubMed Web of Science ®Google Scholar
• Peachey RD, Pye RJ, Harman RR. The treatment of psoriatic nail dystrophy with intradermal steroid injections. Br J Dermatol. 1976;95(1):75–78.
   PubMed Web of Science ®Google Scholar
• Gümüşel M, Özdemir M, Mevlitoğlu I, et al. Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study. J Eur Acad Dermatol Venereol. 2011;25(9):1080–1084.
   PubMed Web of Science ®Google Scholar
• Haneke E. Important malignant and new nail tumors. J Dtsch Dermatol Ges. 2017;15(4):367–386.
   Web of Science ®Google Scholar
• Singal A, Bisherwal K. Melanonychia: etiology, diagnosis, and treatment. Indian Dermatol Online J. 2020;11(1):1–11.
   PubMedGoogle Scholar
• Braun RP, Baran R, Le Gal FA, et al. Diagnosis and management of nail pigmentations. J Am Acad Dermatol. 2007;56(5):835–847.
   PubMed Web of Science ®Google Scholar
• Finch J, Arenas R, Baran R. Fungal melanonychia. J Am Acad Dermatol. 2012;66(5):830–841.
   PubMed Web of Science ®Google Scholar
• Ohn J, Yu DA, Park H, et al. Green nail syndrome: analysis of the association with onychomycosis. J Am Acad Dermatol. 2020;83(3):940–942.
   PubMed Web of Science ®Google Scholar
• Jefferson J, Rich P. Melanonychia. Dermatol Res Pract. 2012;2012:952186.
   PubMedGoogle Scholar
• Metzner MJ, Billington AR, Payne WG. Melanonychia. Eplasty. 2015;15:ic48.
   PubMedGoogle Scholar
• André J, Lateur N. Pigmented nail disorders. Dermatol Clin. 2006;24(3):329–339.
   PubMed Web of Science ®Google Scholar
• Ronger S, Touzet S, Ligeron C, et al. Dermoscopic examination of nail pigmentation. Arch Dermatol. 2002;138(10):1327–1333.
   PubMedGoogle Scholar
• Gradinaru TC, Mihai M, Beiu C, et al. Melanonychia - clues for a correct diagnosis. Cureus. 2020;12(1):e6621.
   PubMed Web of Science ®Google Scholar
• Leung AKC, Lam JM, Leong KF, et al. Melanonychia striata: clarifying behind the black curtain. A review on clinical evaluation and management of the 21st century. Int J Dermatol. 2019;58(11):1239–1245.
   PubMed Web of Science ®Google Scholar
• Piraccini BM, Tosti A. Drug-induced nail disorders: incidence, management and prognosis. Drug Saf. 1999;21(3):187–201.
   PubMed Web of Science ®Google Scholar
• Tosti A, Baran R, Piraccini BM, et al. Nail matrix nevi: a clinical and histopathologic study of twenty-two patients. J Am Acad Dermatol. 1996;34(5 Pt 1):765–771.
   PubMed Web of Science ®Google Scholar
• Metzger S, Ellwanger U, Stroebel W, et al. Extent and consequences of physician delay in the diagnosis of acral melanoma. Melanoma Res. 1998;8(2):181–186.
   PubMed Web of Science ®Google Scholar
• Klausner JM, Inbar M, Gutman M, et al. Nail-bed melanoma. J Surg Oncol. 1987;34(3):208–210.
   PubMed Web of Science ®Google Scholar
• Levit EK, Kagen MH, Scher RK, et al. The ABC rule for clinical detection of subungual melanoma. J Am Acad Dermatol. 2000;42(2 Pt 1):269–274.
   PubMed Web of Science ®Google Scholar
• Ko D, Oromendia C, Scher R, et al. Retrospective single-center study evaluating clinical and dermoscopic features of longitudinal melanonychia, ABCDEF criteria, and risk of malignancy [published correction appears in J Am Acad Dermatol. 2020 Jan; 82(1):260]. J Am Acad Dermatol. 2019;80(5):1272–1283.
   Google Scholar
• Ko D, Lipner SR. Concurrent beau lines, onychomadesis, and retronychia following scurvy. Cutis. 2020;105(3):146–149.
   PubMed Web of Science ®Google Scholar
• Braswell MA, Daniel CR, Brodell RT. Beau lines, onychomadesis, and retronychia: a unifying hypothesis. J Am Acad Dermatol. 2015;73(5):849–855.
   PubMed Web of Science ®Google Scholar
• Piraccini BM, Alessandrini A. Drug-related nail disease. Clin Dermatol. 2013;31(5):618–626.
   PubMed Web of Science ®Google Scholar
• Piraccini BM, Iorizzo M, Starace M, et al. Drug-induced nail diseases. Dermatol Clin. 2006;24(3):387–391.
   PubMed Web of Science ®Google Scholar
• Ben-Dayan D, Mittelman M, Floru S, et al. Transverse nail ridgings (beau's lines) induced by chemotherapy. Acta Haematol. 1994;91(2):89–90.
   PubMed Web of Science ®Google Scholar
• Park J, Li K. Images in clinical medicine. Multiple beau’s lines. N Engl J Med. 2010;362(20):e63.
   PubMedGoogle Scholar
• Piraccini BM, Iorizzo M, Antonucci A, et al. Drug-induced nail abnormalities. Expert Opin Drug Saf. 2004;3(1):57–65.
   PubMedGoogle Scholar
• Baran R. Retinoids and the nails. J. Dermatol. Treat. 1990;1(3):151–154.
   Google Scholar
• Chen HH, Liao YH. Beau’s lines associated with itraconazole. Acta Derm Venereol. 2002;82(5):398.
   PubMed Web of Science ®Google Scholar
• Avery H, Cooper HL, Karim A. Unilateral beau’s lines associated with a fractured olecranon. Australas J Dermatol. 2010;51(2):145–146.
   PubMed Web of Science ®Google Scholar
• Chiu H-H, Liu M-T, Chung W-H, et al. The mechanism of onychomadesis (nail shedding) and beau's lines following hand-foot-mouth disease. Viruses. 2019;11(6):522.
   PubMed Web of Science ®Google Scholar
• Tucker JR. Nail deformities and injuries. Prim Care. 2015;42(4):677–691.
   PubMed Web of Science ®Google Scholar
• Ward DJ, Hudson I, Jeffs JV. Beau’s lines following hand trauma. J Hand Surg Br. 1988;13(4):411–414.
   PubMedGoogle Scholar
• Tosti A, Morelli R, D’Alessandro R, et al. Carpal tunnel syndrome presenting with ischemic skin lesions, acroosteolysis, and nail changes. J Am Acad Dermatol. 1993;29(2 Pt 2):287–290.
   PubMed Web of Science ®Google Scholar
• Egger A, Tosti A. Carpal tunnel syndrome and associated nail changes: review and examples from the author's practice. J Am Acad Dermatol. 2020;83(6):1724–1729.
   PubMed Web of Science ®Google Scholar
• Lee YJ, Yun SK. Unilateral beau’s lines associated with a fingertip crushing injury. J Dermatol. 2005;32(11):914–916.
   PubMed Web of Science ®Google Scholar
• Harford RR, Cobb MW, Banner NT. Unilateral beau’s lines associated with a fractured and immobilized wrist. Cutis. 1995;56(5):263–264.
   PubMed Web of Science ®Google Scholar
• Dawber R. The effect of immobilization on fingernail growth. Clin Exp Dermatol. 1981;6(5):533–535.
   PubMed Web of Science ®Google Scholar
• Wortsman X, Wortsman J, Guerrero R, et al. Anatomical changes in retronychia and onychomadesis detected using ultrasound. Dermatol Surg. 2010;36(10):1615–1620.
   PubMed Web of Science ®Google Scholar
• Hardin J, Haber RM. Onychomadesis: literature review. Br J Dermatol. 2015;172(3):592–596.
   PubMed Web of Science ®Google Scholar
• Bernier V, Labrèze C, Bury F, et al. Nail matrix arrest in the course of hand, foot and mouth disease. Eur J Pediatr. 2001;160(11):649–651.
   PubMed Web of Science ®Google Scholar
• Davia JL, Bel PH, Ninet VZ, et al. Onychomadesis outbreak in Valencia, Spain associated with hand, foot, and mouth disease caused by enteroviruses. Pediatr Dermatol. 2011;28(1):1–5.
   PubMed Web of Science ®Google Scholar
• Osterback R, Vuorinen T, Linna M, et al. Coxsackievirus A6 and hand, foot, and mouth disease, Finland. Emerg Infect Dis. 2009;15(9):1485–1488.
   PubMed Web of Science ®Google Scholar
• Wei SH, Huang YP, Liu MC, et al. An outbreak of coxsackievirus A6 hand, foot, and mouth disease associated with onychomadesis in Taiwan. BMC Infect Dis. 2011;11(1):346.
   PubMed Web of Science ®Google Scholar
• Chu DH, Rubin AI. Diagnosis and management of nail disorders in children. Pediatr Clin North Am. 2014;61(2):293–308.
   PubMed Web of Science ®Google Scholar
• Acharya S, Balachandran C. Onychomadesis in stevens johnson syndrome. Indian J Dermatol Venereol Leprol. 1996;62(4):264–265.
   PubMedGoogle Scholar
• Ciastko AR. Onychomadesis and Kawasaki disease. CMAJ. 2002;166(8):1069.
   PubMed Web of Science ®Google Scholar
• Patel NC, Silverman RA. Neonatal onychomadesis with candidiasis limited to affected nails. Pediatr Dermatol. 2008;25(6):641–642.
   PubMed Web of Science ®Google Scholar
• Mazereeuw-Hautier J, Bonafé JL. Bilateral beau’s lines and pyogenic granulomas following Guillain-Barré syndrome. Dermatology. 2004;209(3):237–238.
   PubMed Web of Science ®Google Scholar
• LaRow JA, Mysliborski J, Rappaport IP, et al. Alopecia areata universalis in an infant. J Cutan Med Surg. 2001;5(2):131–134.
   PubMed Web of Science ®Google Scholar
• Habibi M, Mortazavi H, Shadianloo S, et al. Nail changes in pemphigus vulgaris. Int J Dermatol. 2008;47(11):1141–1144.
   PubMed Web of Science ®Google Scholar
• Suchonwanit P, Nitayavardhana S. Idiopathic sporadic onychomadesis of toenails. Case Rep Dermatol Med. 2016;2016:6451327.
   PubMedGoogle Scholar
• Martin S, Rudolph AH. Familial dystrophic periodic shedding of the nails. Cutis. 1980;25(6):622–623.
   PubMed Web of Science ®Google Scholar
• de Berker DA, Richert B, Duhard E, et al. Retronychia: proximal ingrowing of the nail plate. J Am Acad Dermatol. 2008;58(6):978–983.
   PubMed Web of Science ®Google Scholar
• de Mello CDBF, Souza MDRE, Noriega LF, et al. Retronychia. An Bras Dermatol. 2018;93(5):707–711.
   PubMed Web of Science ®Google Scholar
• Pessoa E Costa T, João AL, Lencastre A. Retronychia: a paradigm shift? Skin Appendage Disord. 2020;6(5):268–271.
   PubMed Web of Science ®Google Scholar
• Ventura F, Correia O, Duarte AF, et al. Retronychia-clinical and pathophysiological aspects. J Eur Acad Dermatol Venereol. 2016;30(1):16–19.
   PubMed Web of Science ®Google Scholar
• Au AS, Leung WY, Tran D. Retronychia: a literature review. J Am Podiatr Med Assoc. 2020;110(3)Article_9.
   PubMed Web of Science ®Google Scholar
• Salgado F, Handler MZ, Schwartz RA. Shedding light on onychomadesis. Cutis. 2017;99(1):33–36.
   PubMed Web of Science ®Google Scholar
• Nanda S, Grover C. Utility of gel nails in improving the appearance of cosmetically disfigured nails: experience with 25 cases. J Cutan Aesthet Surg. 2014;7(1):26–31.
   PubMedGoogle Scholar
• Fleming CJ, Hunt MJ, Barnetson RS. Mycosis fungoides with onychomadesis. Br J Dermatol. 1996;135(6):1012–1013.
   PubMed Web of Science ®Google Scholar
• Mishra D, Singh G, Pandey SS. Possible carbamazepine-induced reversible onychomadesis. Int J Dermatol. 1989;28(7):460–461.
   PubMed Web of Science ®Google Scholar
• Kim HS, Lee SH, Yoon TJ, et al. Early stage onychomadesis presenting as painful swellings of proximal nail folds. Cutis. 2001;67(4):317–318.
   PubMed Web of Science ®Google Scholar
• Piraccini BM, Richert B, de Berker DA, et al. Retronychia in children, adolescents, and young adults: a case series. J Am Acad Dermatol. 2014;70(2):388–390.
   PubMed Web of Science ®Google Scholar
• Vastarella M, Annunziata MC, Panariello L, et al. A novel treatment for retronychia: case series. J Dermatolog Treat. 2020;31(3):254–255.
   PubMed Web of Science ®Google Scholar